Your browser doesn't support javascript.
loading
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian, Gayathri; Schwarz, Roderich E; Higgins, Linda; McEnroe, Glenn; Chakravarty, Sarvajit; Dugar, Sundeep; Reiss, Michael.
Affiliation
  • Subramanian G; Departments of Internal Medicine (Medical Oncology), The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA.
Cancer Res ; 64(15): 5200-11, 2004 Aug 01.
Article in En | MEDLINE | ID: mdl-15289325
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Signal Transduction / Trans-Activators / Receptors, Transforming Growth Factor beta / Activin Receptors, Type I / DNA-Binding Proteins / Neoplasm Invasiveness Limits: Humans Language: En Journal: Cancer Res Year: 2004 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Signal Transduction / Trans-Activators / Receptors, Transforming Growth Factor beta / Activin Receptors, Type I / DNA-Binding Proteins / Neoplasm Invasiveness Limits: Humans Language: En Journal: Cancer Res Year: 2004 Document type: Article Affiliation country: United States Country of publication: United States